Quest Diagnostics Incorporated

US$255.63As of Sun 8 Nov 2026, 12:00 UTC
NYSE:DGXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 14.31%
Div yield 1.35%
ROE 15.32%
Diagnostics & Research
Beta (5Y) 0.55
PE TTM 25.47
TSR TTM 47.73%
Mkt cap US$28.12B
ROIC 10.03%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$309
21.01%
(74.11%)
Hold 7|10|3|8|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
3.73
3.64
3.75
3.64
12.63%
13.14%
9.46%
2.21%
Revenue$B
1.474
1.455
1.445
1.457
18.10%
9.99%
6.58%
2.60%
Peers (US$28.12B)
Cap (US$)
PE
32.23B
36.58x
29.77B
30.10x
34.25B
37.31x
Capital
TTM
5Y
10Y
Leveragex
7.479
0.707
0.597
EBIT/Intx
0.721
0.127
0.113
Own earn%
(26.14)
(36.49)
(25.60)
Sh yield%
20.25
29.18
28.12
Owners
Insiders/Inst%
5.58
21.82
Short interest%
4.36
SBC / revenue%
5.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
14–18
$1 testx
0.0
Incr. ROIC%
7